Hope & Heal Cancer Hospital And Research Center Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 18-12-2024
- Paid Up Capital ₹ 5.00 Cr
as on 18-12-2024
- Company Age 4 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 53.75 Cr
as on 18-12-2024
- Revenue 1654.38%
(FY 2023)
- Profit 1291.61%
(FY 2023)
- Ebitda -274.58%
(FY 2023)
- Net Worth 4962.07%
(FY 2023)
- Total Assets 2184.98%
(FY 2023)
About Hope & Heal Cancer Hospital And Research Center
The Corporate was formerly known as Hope & Heal Cencar Hospital And Research Center Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹53.75 Cr.
Kalpana Roy and Saptarshi Ghosh serve as directors at the Company.
- CIN/LLPIN
U85300WB2020PTC241653
- Company No.
241653
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Jalpaiguri, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Hope & Heal Cancer Hospital And Research Center?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kalpana Roy | Director | 02-Dec-2020 | Current |
Saptarshi Ghosh | Director | 02-Dec-2020 | Current |
Financial Performance of Hope & Heal Cancer Hospital And Research Center.
Hope & Heal Cancer Hospital And Research Center Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1654.38% increase. The company also saw a substantial improvement in profitability, with a 1291.61% increase in profit. The company's net worth Soared by an impressive increase of 4962.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Hope & Heal Cancer Hospital And Research Center?
In 2023, Hope & Heal Cancer Hospital And Research Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 09 Sep 2022 | ₹53.75 Cr | Open |
How Many Employees Work at Hope & Heal Cancer Hospital And Research Center?
Unlock and access historical data on people associated with Hope & Heal Cancer Hospital And Research Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hope & Heal Cancer Hospital And Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hope & Heal Cancer Hospital And Research Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.